✨ Health and Medicines Notices




1826

NEW ZEALAND GAZETTE

No. 79

Dated at Wellington this 25th day of June 1999.

KATHY PHILLIPS, Senior Manager, National Operations.

go4772

Health

Health Reforms (Transitional Provisions) Act 1993

Appointment of Directors of Residual Health Management Unit

Pursuant to section 18(2) of the Health Reforms (Transitional Provisions) Act 1993, and in accordance with clause 3 of the Second Schedule to the Health and Disability Services Act 1993, I re-appoint each of the following persons as a director of the board of the Residual Health Management Unit for the term specified for that person on the conditions specified in the Schedule to this notice.

Pursuant to clause 2(1) of the Second Schedule to the Health and Disability Services Act 1993, I appoint Ian Miller as chairperson of the board of the Residual Health Management Unit, commencing on the 1st day of July 1999 and expiring on the 30th day of June 2000.

Director Term of Re-Appointment
Ian Miller 1 July 1999–30 June 2000
Peter Farley 1 July 1999–30 June 2000

Schedule

Compliance with the Management Agreement dated 30 September 1993 between the Minister of Health and the Residual Health Management Unit.

Dated at Wellington this 30th day of June 1999.

HON. WYATT CREECH, Minister of Health.

go4787


Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Trade Name: Complete ComfortPlus.

Dosage Form: Contact lens solution.

NZ Sponsor: Allergan New Zealand Limited.

Active Ingredient(s): Hypromellose 1.5 mg/mL.

Poloxamers 0.5 mg/mL.

Polyhexamethylene Biguanide 0.001 mg/mL.

Manufacturer(s): Allergan Pharmaceuticals (Ireland) Limited, Westport, County Mayo, Ireland.

Trade Name: Cycrin.

Dosage Form: Tablet.

NZ Sponsor: Wyeth (NZ) Limited.

Active Ingredient(s): Medroxyprogesterone acetate 2.5 mg.

Manufacturer(s): Wyeth Medica Ireland, Newbridge, County Kildare, Ireland.

Trade Name: Cycrin.

Dosage Form: Tablet.

NZ Sponsor: Wyeth (NZ) Limited.

Active Ingredient(s): Medroxyprogesterone acetate 5 mg.

Manufacturer(s): Wyeth Medica Ireland, Newbridge, County Kildare, Ireland.

Trade Name: Cycrin.

Dosage Form: Tablet.

NZ Sponsor: Wyeth (NZ) Limited.

Active Ingredient(s): Medroxyprogesterone acetate 10 mg.

Manufacturer(s): Wyeth Medica Ireland, Newbridge, County Kildare, Ireland.

Trade Name: Nurofen Advance.

Dosage Form: Film coated tablet.

NZ Sponsor: Boots Healthcare New Zealand Limited.

Active Ingredient(s): Ibuprofen lysinate 342 mg equivalent to 200 mg ibuprofen.



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1999, No 79


NZLII PDF NZ Gazette 1999, No 79





✨ LLM interpretation of page content

πŸ₯ Appointment of Directors of Residual Health Management Unit

πŸ₯ Health & Social Welfare
30 June 1999
Health Reforms (Transitional Provisions) Act 1993, Residual Health Management Unit, Appointments
  • Ian Miller, Appointed chairperson and director of the board
  • Peter Farley, Re-appointed director of the board

  • HON. WYATT CREECH, Minister of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
Medicines Act 1981, New Medicines, Consent to Distribution